RESEARCH AND CLINICAL TRIALS OVERVIEW

Since 1989, CRI has been on the forefront of HIV/AIDS clinical research. The high-quality data resulting from CRI’s research and clinical trials have contributed to FDA approval of nearly all of the HIV drugs available today.

CRI’s clinical research trials play a crucial role in accelerating the discovery of safe new HIV treatments that enable participants to be more active in their own healthcare, gain access to new treatments before they become widely available and to help others by contributing to medical research.

Seeking answers to important questions that no one else is asking, CRI has also initiated more than 50 of its own innovative physician-led research studies that continue to play a critical role in shaping the effectiveness of HIV treatment and improving the quality of HIV patient care around the world.

August 2, 2010: Community Research Initiative of New England (CRI) announced today that it will transfer its Springfield-based HIV clinical trials to Baystate Medical Center (BMC) in Springfield, MA. CRI West’s current research team – led by Dr. Daniel Skiest and Dr. Armando Paez – will continue its state-of-the art HIV, viral hepatitis, and pneumococcal vaccine research at Baystate Medical Center as BMC becomes a collaborating CRI Research Network site. For more information, please click here or contact Sharon Gray at 617.510.1710 or sgray@crine.org

To see some FAQs about the clinical research process and the role of participants in clinical research trials, please click here.

To go directly to a list of CRI's open and enrolling trials, please click here.